Home/Supreme Court/Merck Kgaa v. Integra Lifesciences I, Ltd.

Merck Kgaa v. Integra Lifesciences I, Ltd.

543 U.S. 1041, 125 S. Ct. 823, 160 L. Ed. 2d 609, 73 U.S.L.W. 3396, 2005 U.S. LEXIS 614
CourtSupreme Court of the United States
DecidedJanuary 7, 2005
Docket03-1237
StatusPublished

This text of 543 U.S. 1041 (Merck Kgaa v. Integra Lifesciences I, Ltd.) is published on Counsel Stack Legal Research, covering Supreme Court of the United States primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Merck Kgaa v. Integra Lifesciences I, Ltd., 543 U.S. 1041, 125 S. Ct. 823, 160 L. Ed. 2d 609, 73 U.S.L.W. 3396, 2005 U.S. LEXIS 614 (2005).

Opinion

C. A. Fed. Cir. Motion of Eli Lilly and Company for leave to file a brief as amicus curiae granted. Certiorari granted.

Justice O’Connor and Justice Breyer took no part *1042 in the consideration or decision of this motion and this petition.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Integra Lifesciences I, Ltd. v. Merck Kgaa
331 F.3d 860 (Federal Circuit, 2003)

Cite This Page — Counsel Stack

Bluebook (online)
543 U.S. 1041, 125 S. Ct. 823, 160 L. Ed. 2d 609, 73 U.S.L.W. 3396, 2005 U.S. LEXIS 614, Counsel Stack Legal Research, https://law.counselstack.com/opinion/merck-kgaa-v-integra-lifesciences-i-ltd-scotus-2005.